US5098835A - Process for producing l-threonine by fermentation - Google Patents
Process for producing l-threonine by fermentation Download PDFInfo
- Publication number
- US5098835A US5098835A US07/357,690 US35769089A US5098835A US 5098835 A US5098835 A US 5098835A US 35769089 A US35769089 A US 35769089A US 5098835 A US5098835 A US 5098835A
- Authority
- US
- United States
- Prior art keywords
- threonine
- sub
- leucine
- providencia rettgeri
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 title claims abstract description 75
- 238000000855 fermentation Methods 0.000 title claims abstract description 15
- 230000004151 fermentation Effects 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims description 10
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 49
- 239000004473 Threonine Substances 0.000 claims abstract description 38
- 229960002898 threonine Drugs 0.000 claims abstract description 38
- 244000005700 microbiome Species 0.000 claims abstract description 32
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 3
- 241000588777 Providencia rettgeri Species 0.000 claims description 34
- 238000012258 culturing Methods 0.000 claims description 3
- 241000588768 Providencia Species 0.000 abstract description 7
- 241000894007 species Species 0.000 abstract 1
- 229960003136 leucine Drugs 0.000 description 24
- 239000004395 L-leucine Substances 0.000 description 23
- 235000019454 L-leucine Nutrition 0.000 description 23
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 16
- 229930182844 L-isoleucine Natural products 0.000 description 16
- 229960000310 isoleucine Drugs 0.000 description 16
- 239000002609 medium Substances 0.000 description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 12
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 12
- 239000008103 glucose Substances 0.000 description 12
- 229920001817 Agar Polymers 0.000 description 11
- 239000008272 agar Substances 0.000 description 11
- LGVJIYCMHMKTPB-UHFFFAOYSA-N 3-hydroxynorvaline Chemical compound CCC(O)C(N)C(O)=O LGVJIYCMHMKTPB-UHFFFAOYSA-N 0.000 description 10
- GGLZPLKKBSSKCX-YFKPBYRVSA-N L-ethionine Chemical compound CCSCC[C@H](N)C(O)=O GGLZPLKKBSSKCX-YFKPBYRVSA-N 0.000 description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- VKTCMMONRNFKJD-BYPYZUCNSA-N (2r)-3-aminosulfanyl-2-(ethylamino)propanoic acid Chemical compound CCN[C@H](C(O)=O)CSN VKTCMMONRNFKJD-BYPYZUCNSA-N 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 6
- 102000002667 Glycine hydroxymethyltransferase Human genes 0.000 description 5
- 108010043428 Glycine hydroxymethyltransferase Proteins 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000011218 seed culture Methods 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- -1 ethionine Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- NZWPVDFOIUKVSJ-YFKPBYRVSA-N (2s)-2,6-diamino-n-hydroxyhexanamide Chemical compound NCCCC[C@H](N)C(=O)NO NZWPVDFOIUKVSJ-YFKPBYRVSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- ASYBZHICIMVQII-UHFFFAOYSA-N 4-hydroxylysine Chemical compound NCCC(O)CC(N)C(O)=O ASYBZHICIMVQII-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003868 ammonium compounds Chemical class 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 150000002741 methionine derivatives Chemical class 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000003867 organic ammonium compounds Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000012607 strong cation exchange resin Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 150000003588 threonines Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/873—Proteus
Definitions
- This invention relates to a process for producing L-threonine by fermentation.
- One object of the present invention is to provide an improved process for producing L-threonine by fermentation which can give a much higher accumulated amount and yield.
- Another object of the invention is to provide an improved process using novel mutanized microorganisms for producing L-threonine.
- a process for producing L-threonine by fermentation which comprises the steps of:
- the microorganism used in the present invention belongs to the genus Providencia.
- the genus is decided according to Bergy's Manual of Systematic Bacteriology Volume 1 (1984) pages 495 to 496.
- the microorganism used in the invention requires at least L-leucine for the growth thereof and is capable of producing L-threonine.
- lysine analog means (i) a substance which can inhibit the growth of the microorganism belonging to the genus Providencia, such an inhibition being reversed by supplement of lysine, or (ii) a substance which can repress or inhibit enzyme in the biosynthetic pathway of L-lysine.
- lysine analog examples are S-aminoethyl-L-cystein, lysine hydroxamate, 4-hydroxylysine, and so on.
- S-aminoethyl-L-cystein is most preferably used.
- microorganisms which have further characters selected from the character requiring L-isoleucine for the growth thereof, the character having resistance to threonine analog such as ⁇ -amino- ⁇ -hydroxyvaleric acid, and the character having resistance to methionine analog such as ethionine, adding to at least one character of the character lacking threonine aldolase and the character having a resistance to lysine analog.
- microorganisms which have some or all of the characters above mentioned. These characters can be given to the microorganisms by conventional methods.
- auxotrophy namely requiring a nutrient for the growth thereof, means a wide concept and includes the leaky type, namely the incomplete defect type, and further includes the case when auxotrophy is supplied with a biosynthetic precursor of the required nutrient.
- microorganisms useful for the invention are as follows:
- This NS-140 strain has a resistance to ⁇ -amino- ⁇ -hydroxyvaleric acid and ethionine; and requires L-isoleucine and L-leucine for the growth thereof, and was deposited with Fermentation Research Institute in Japan on Feb. 12, 1985.
- This NS133I-69 strain has a resistance to ⁇ -amino- ⁇ -hydroxyvaleric acid and ethionine; requires L-isoleucine and L-leucine for the growth thereof; and lacks threonine aldolase, and was deposited with Fermentation Research Institute in Japan on Feb. 12, 1985.
- This TP4-105-43 strain has a resistance to ⁇ -amino- ⁇ -hydroxyvaleric acid, L-ethionine, and S-aminoethyl-L-cysteine; and requires L-isoleucine and L-leucine for the growth thereof, and was deposited with Fermentation Research Institute in Japan on July 15, 1985.
- the FERM BP numbers are the access number of the Fermentation Research Institute Agency of Industrial Science and Technology, at No. 1-3, Yatabe-cho, Higashi 1-chome, Tsukuba-gun, Ibaragi-ken, 305 JAPAN, from which the microorganisms with FERM BP numbers are available to any party who requests them.
- threonine producing microorganisms can be derived as a mutant, for example, from the following parent strains of Proteus rettgeri which is the previous name of Providencia rettgeri;
- This NS-133 strain has a resistance to ⁇ -amino- ⁇ -hydroxyvaleric acid and ethionine; requires L-isoleucine for the growth thereof; and lacks threonine aldolase, and is a parent strain of NS133I-69.
- NS133I-69 strain is a parent strain of TP3-105 which is a parent strain of TP4-105-43.
- methods for inducing the mutants are conventional methods such as irradiation with ultraviolet light, or treatment with N-methyl-N'-nitro-N-nitrosoguanidine or ethylmethane sulfonate, etc.
- the mutagenized cells are spread on the minimal agar plates containing a small amount of casamino acid (Trade Mark) or yeast extract and cultivated at 30° C. for 3 or 5 days. Smaller colonies formed on the agar plates are isolated, and the colony which requires L-leucine for the growth thereof is selected.
- the microorganisms having a resistance to lysine analog when used, we define the microorganisms for the present invention as a strain which can grow and form colonies on a minimal medium supplemented with 2.5 g/l of lysine analog and of which the growth degree after the cultivation for 24 hours is at least 50%, based on the case in the absence of lysine analog.
- growth degree is shown by the relative optical density of the culture broth at 660 nm when the optical density of culture broth in non-supplement of lysine analog is defined as 100%.
- the processes for producing L-threonine using the microorganisms are conventional, and the microorganisms are cultivated in a conventional medium containing carbon sources, nitrogen sources, inorganic salts and other necessary organic minor nutrients.
- carbohydrates such as glucose, fructose, starch, cellulose hydrolysate, or molasses
- organic acids such as fumaric acid, citric acid, or succinic acid
- alcohols such as glycerol.
- organic ammonium compounds such as ammonium acetate, or urea
- inorganic ammonium compounds such as ammonium sulfate, ammonium chloride, ammonium phosphate, or ammonimum nitratc
- ammonia gas or aqueous ammonia.
- potassium phosphate potassium phosphate
- magnesium sulfate ferrous sulfate 7-hydrate or 4-to 6-hydrate of manganese sulfate.
- the preferable culture medium may contain 2 to 15% of carbon source, 0.5 to 4.0% of nitrogen source, and 0.001 to 0.4% of required organic material, 0 to 4% of natural organic nutrient and a minor amount of inorganic nutrient.
- Cultivation is carried out under aerobic conditions such as being shaken or stirred with aeration at a temperature from 24° to 37° C. for 48 to 120 hours. During cultivation the pH of the medium is adjusted to 5 to 9.
- L-threonine in the culture broth thus obtained can be separated by a known method, for example, by means of ion-exchange resins.
- the microorganisms are removed from the culture broth with centrifuging, and the resulting culture broth solution is adjusted to pH 2 by hydrochloric acid, and then the broth solution is passed through a strongly acidic cation exchange resin. Thereafter, the adsorbant is eluted by dilute aqueous ammonia. Ammonia is evaporated from the resulting eluent, and then the resulting solution is condensed. Alcohol is added to the resultant and left standing under cooling to give crystals of L-threonine.
- Providencia rettgeri TY-1and NS-133 were irradiated with ultraviolet light by a conventional method, respectively.
- the mutagenized cells were spread on the agar plates shown in Table 1.
- NS-140 strain which has a resistance to a ⁇ -amino- ⁇ -hydroxyvaleric acid and ethionine and requires L-isoleucine and L-leucine
- NS133I-69 strain which has a resistance to ⁇ -amino - ⁇ -hydroxyvaleric acid and ethionine, requires L-isoleucine and L-leucine for the growth thereof, and lacks threonine aldolase, was obtained from the parent NS-133 strain.
- TP3-105 strain which has a resistance to ⁇ -amino- ⁇ -hydroxyvaleric acid and L-ethionine, and requires L-isoleucine and L-leucine, was obtained.
- TP3-105 strain was treated with N-methyl-N'-nitro-N-nitrosoguanidine by a conventional method (300 ⁇ g/ml, 30° C., 10 minutes).
- the mutagenized cells were spread on the agar plate shown in Table 2.
- TP4-105-43 strain which has a resistance to ⁇ -amino- ⁇ -hydroxyvaleric acid, L-ethionine and S-aminoethyl-L-cysteine and requires L-isoleucine and L-leucine for the growth thereof.
- Each strain showing in Table 4 was cultivated on nutrient agar slant for 24 hours. The resulting strains were placed on the minimal agar plate shown in Table 3 containing no L-leucine and 0.01% of L-leucine and cultivated at 30° C. for 4 days.
- the growth degree was measured.
- the mutant requiring L-leucine was determined by one which is incapable or difficult to grow in the absence of L-leucine and capable to grow in the presence of L-leucine.
- Providencia rettgeri NS-140, NS133I-69, and TP4-105-43 apparently require L-leucine for the growth thereof, while Providencia rettgeri TY-1 and NS-133 which are parent strains, do not.
- Each microorganism shown in Table 6 was cultivated in bouillon liquid at 30° C. for 16 hours with shaking, was harvested, and washed well with physiological saline.
- the resulting cell suspension of each microorganism was inoculated into 5 ml of the minimal medium shown in Table 5 containing 0 g/l, 2.5 g/l, 5 g/l, 7.5 g/l, 10 g/l, respectively, and cultivated at 30° C. for 14 hours.
- the growth degree was measured.
- Each microorganism shown in Table 8 was cultivated in bouillon liquid at 30° C. for 16 hours with shaking to give a seed culture broth. Then, 4 ml of seed culture broth was inoculated into 40 ml of the fermentation medium shown in Table 7 in 1-liter shaking flask. Cultivation was carried out at 30° C. for 90 hours with shaking conditions 150 rpm, 3 cm stroke).
- the amounts of L-threonine accumulated and the yields were efficiently improved, compared with the parent strains.
- Providencia rettgeri NS-140 was cultivated in bouillon liquid medium at 30° C. for 16 hours with shaking to give a seed culture broth.
- 100 ml of the seed culture was transferred into a 2-liter jar fermentor, which contained 900 ml of the same fermentation medium as used in Example 1 except that 0.5% of (NH 4 ) 2 SO 4 and 4.0% of glucose was used.
- Cultivation was carried out at 30° C. with agitation (800 rpm) and with aeration (1 liter of air per min).
- PH was controlled to 6.5 to 8.0 by 25% aqueous ammonia which was used as a nitrogen source.
- glucose was fed intermittently and 150 g of glucose was consumed.
- the culture broth was centrifuged and the microorganisms were removed off from the culture broth.
- 500 ml of the filtrate was passed through a column packed with supernatant strong cation exchange resin DIAION (Trade Mark) SK ⁇ 1B [H type]. Then, the column was washed with water and thereafter the adsorbant in column was eluted by 2N aqueous ammonia. The eluent was decolorized and condensed under reduced pressure. Alcohol was added to the resultant and left standing under cooling to give crystals of L-threonine. The crystals were gathered, dried to give 11.5 g of L-threonine having 96% of the purity.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Microorganisms belonging to the genus Providencia the species rettgeri at least leucine for the growth thereof, produce L-threonine by fermentation in higher yield and with increased amount of L-threonine accumulated.
Description
This application is a continuation of application Ser. No. 861,076, filed May 8, 1986, now abandoned.
(a) FIELD OF THE INVENTION
This invention relates to a process for producing L-threonine by fermentation.
(b) PRIOR ART
It hitherto has been known that the microorganism belonging to the genus Proteus or Providencia of which the mutant requires L-isoleucine, can be used as microorganisms capable of producing L-threonine by fermentation (Japanese Examined Patent Publication No. 4440/1968).
However, there is room for further improvement in the capability of the strains as to the amount of L-threonine accumulated and as to the yield of L-threonine from the starting material such as glucose or fructose.
One object of the present invention is to provide an improved process for producing L-threonine by fermentation which can give a much higher accumulated amount and yield.
Another object of the invention is to provide an improved process using novel mutanized microorganisms for producing L-threonine.
These and other objects of the invention will become more apparent in the detailed description and examples hereinafter.
These objects are attained by
A process for producing L-threonine by fermentation which comprises the steps of:
(a) culturing an L-threonine producing microorganism belonging to the genus Providencia until L-threonine is accumulated in a culture broth, said microorganism requiring at least leucine for the growth thereof and
(b) recovering the accumulated L-threonine from the culture broth.
The microorganism used in the present invention belongs to the genus Providencia. The genus is decided according to Bergy's Manual of Systematic Bacteriology Volume 1 (1984) pages 495 to 496. Moreover, the microorganism used in the invention requires at least L-leucine for the growth thereof and is capable of producing L-threonine. In the invention there may preferably be employed microorganisms which further have the character of lacking threonine aldolase and/or the character of having resistance to lysine analog.
In the invention "lysine analog" means (i) a substance which can inhibit the growth of the microorganism belonging to the genus Providencia, such an inhibition being reversed by supplement of lysine, or (ii) a substance which can repress or inhibit enzyme in the biosynthetic pathway of L-lysine.
Preferable examples of the lysine analog are S-aminoethyl-L-cystein, lysine hydroxamate, 4-hydroxylysine, and so on. As for the lysine analog S-aminoethyl-L-cystein is most preferably used.
These characters effectively operate the capability of producing L-threonine.
Moreover, there may be more preferably employed microorganisms which have further characters selected from the character requiring L-isoleucine for the growth thereof, the character having resistance to threonine analog such as α-amino-β-hydroxyvaleric acid, and the character having resistance to methionine analog such as ethionine, adding to at least one character of the character lacking threonine aldolase and the character having a resistance to lysine analog.
These characters also effectively operate the capability of producing L-threonine. Therefore, there may be more preferably employed microorganisms which have some or all of the characters above mentioned. These characters can be given to the microorganisms by conventional methods.
In the present invention, auxotrophy, namely requiring a nutrient for the growth thereof, means a wide concept and includes the leaky type, namely the incomplete defect type, and further includes the case when auxotrophy is supplied with a biosynthetic precursor of the required nutrient.
Representative microorganisms useful for the invention are as follows:
This NS-140 strain has a resistance to α-amino-β-hydroxyvaleric acid and ethionine; and requires L-isoleucine and L-leucine for the growth thereof, and was deposited with Fermentation Research Institute in Japan on Feb. 12, 1985.
This NS133I-69 strain has a resistance to α-amino-β-hydroxyvaleric acid and ethionine; requires L-isoleucine and L-leucine for the growth thereof; and lacks threonine aldolase, and was deposited with Fermentation Research Institute in Japan on Feb. 12, 1985.
This TP4-105-43 strain has a resistance to α-amino-β-hydroxyvaleric acid, L-ethionine, and S-aminoethyl-L-cysteine; and requires L-isoleucine and L-leucine for the growth thereof, and was deposited with Fermentation Research Institute in Japan on July 15, 1985.
The FERM BP numbers are the access number of the Fermentation Research Institute Agency of Industrial Science and Technology, at No. 1-3, Yatabe-cho, Higashi 1-chome, Tsukuba-gun, Ibaragi-ken, 305 JAPAN, from which the microorganisms with FERM BP numbers are available to any party who requests them.
These threonine producing microorganisms can be derived as a mutant, for example, from the following parent strains of Proteus rettgeri which is the previous name of Providencia rettgeri;
(i) Providencia rettgeri TY-1 (FERM P-8079) This TY-1 strain has a resistance to α-amino-β-hydroxyvaleric acid and ethionine; and requires L-isoleucine for the growth thereof and is a parent strain of NS-140.
(ii) Providencia rettgeri NS-133 (FERM P-8079)
This NS-133 strain has a resistance to α-amino-β-hydroxyvaleric acid and ethionine; requires L-isoleucine for the growth thereof; and lacks threonine aldolase, and is a parent strain of NS133I-69. Moreover, NS133I-69 strain is a parent strain of TP3-105 which is a parent strain of TP4-105-43.
In the invention, methods for inducing the mutants are conventional methods such as irradiation with ultraviolet light, or treatment with N-methyl-N'-nitro-N-nitrosoguanidine or ethylmethane sulfonate, etc. After the irradiation or treatment, the mutagenized cells are spread on the minimal agar plates containing a small amount of casamino acid (Trade Mark) or yeast extract and cultivated at 30° C. for 3 or 5 days. Smaller colonies formed on the agar plates are isolated, and the colony which requires L-leucine for the growth thereof is selected.
When the microorganisms having a resistance to lysine analog is used, we define the microorganisms for the present invention as a strain which can grow and form colonies on a minimal medium supplemented with 2.5 g/l of lysine analog and of which the growth degree after the cultivation for 24 hours is at least 50%, based on the case in the absence of lysine analog. In the invention, growth degree is shown by the relative optical density of the culture broth at 660 nm when the optical density of culture broth in non-supplement of lysine analog is defined as 100%.
The processes for producing L-threonine using the microorganisms are conventional, and the microorganisms are cultivated in a conventional medium containing carbon sources, nitrogen sources, inorganic salts and other necessary organic minor nutrients.
There can be used as a carbon source, carbohydrates such as glucose, fructose, starch, cellulose hydrolysate, or molasses; organic acids such as fumaric acid, citric acid, or succinic acid; or alcohols such as glycerol.
There can be used as a nitrogen source, organic ammonium compounds such as ammonium acetate, or urea; inorganic ammonium compounds such as ammonium sulfate, ammonium chloride, ammonium phosphate, or ammonimum nitratc; ammonia gas; or aqueous ammonia.
There can be preferably used as organic nutrients corn steep liquor, polypeptone, or yeast extract.
There can be used as an inorganic salt, potassium phosphate, magnesium sulfate, ferrous sulfate 7-hydrate or 4-to 6-hydrate of manganese sulfate.
The preferable culture medium may contain 2 to 15% of carbon source, 0.5 to 4.0% of nitrogen source, and 0.001 to 0.4% of required organic material, 0 to 4% of natural organic nutrient and a minor amount of inorganic nutrient.
Cultivation is carried out under aerobic conditions such as being shaken or stirred with aeration at a temperature from 24° to 37° C. for 48 to 120 hours. During cultivation the pH of the medium is adjusted to 5 to 9.
After cultivation, L-threonine in the culture broth thus obtained can be separated by a known method, for example, by means of ion-exchange resins. In order to recover the accumulated L-threonine from the culture broth, the microorganisms are removed from the culture broth with centrifuging, and the resulting culture broth solution is adjusted to pH 2 by hydrochloric acid, and then the broth solution is passed through a strongly acidic cation exchange resin. Thereafter, the adsorbant is eluted by dilute aqueous ammonia. Ammonia is evaporated from the resulting eluent, and then the resulting solution is condensed. Alcohol is added to the resultant and left standing under cooling to give crystals of L-threonine.
The invention will be more clearly understood with reference to the following Experiments and Examples. However, these Experiments and Examples are intended to illustrate the invention and are not to be construed as limiting the scope of the invention.
Providencia rettgeri TY-1and NS-133 were irradiated with ultraviolet light by a conventional method, respectively. The mutagenized cells were spread on the agar plates shown in Table 1.
TABLE 1
______________________________________
COMPONENTS OF MEDIUM FOR AGAR PLATE
______________________________________
Glucose 0.5%
(NH.sub.4).sub.2 SO.sub.4
0.1%
KH.sub.2 PO.sub.4
0.3%
K.sub.2 HPO.sub.4
0.7%
MgSO.sub.4.7H.sub.2 O
0.01%
L-isoleucine 0.005%
Polypeptone 0.01%
Agar 2%
______________________________________
Then, the agar plates were incubated for 4 to 6 days at 30° C. In the colonies formed on the plate, smaller colonies were picked up from the colonies formed on the plate. NS-140 strain, which has a resistance to a α-amino-β-hydroxyvaleric acid and ethionine and requires L-isoleucine and L-leucine, was obtained from the parent TY-1 strain. NS133I-69 strain, which has a resistance to α-amino -β-hydroxyvaleric acid and ethionine, requires L-isoleucine and L-leucine for the growth thereof, and lacks threonine aldolase, was obtained from the parent NS-133 strain.
Providencia rettgeri NS133I-69 strain was irradiated with ultraviolet light by a similar manner to Experiment 1. TP3-105 strain, which has a resistance to α-amino-β-hydroxyvaleric acid and L-ethionine, and requires L-isoleucine and L-leucine, was obtained. TP3-105 strain was treated with N-methyl-N'-nitro-N-nitrosoguanidine by a conventional method (300 μg/ml, 30° C., 10 minutes).
The mutagenized cells were spread on the agar plate shown in Table 2.
TABLE 2
______________________________________
COMPONENTS OF MEDIUM FOR AGAR PLATE
______________________________________
Glucose 0.5%
(NH.sub.4).sub.2 SO.sub.4
0.1%
KH.sub.2 PO.sub.4 0.3%
K.sub.2 HPO.sub.4 0.7%
MgSO.sub.4.7H.sub.2 O 0.01%
L-leucine 0.005%
S-aminoethyl-L-cysteine 0.8%
L-threonine 1.0%
L-isoleucine 1.0%
L-methionine 1.0%
Agar 2%
______________________________________
Then the agar plates were incubated for 5 to 7 days at 30° C. In the colonies formed on the plate, larger colony was picked up from colonies formed on the plate and obtained TP4-105-43 strain which has a resistance to α-amino-β-hydroxyvaleric acid, L-ethionine and S-aminoethyl-L-cysteine and requires L-isoleucine and L-leucine for the growth thereof.
Each strain showing in Table 4 was cultivated on nutrient agar slant for 24 hours. The resulting strains were placed on the minimal agar plate shown in Table 3 containing no L-leucine and 0.01% of L-leucine and cultivated at 30° C. for 4 days.
TABLE 3
______________________________________
COMPONENTS OF MINIMAL
MEDIUM FOR AGAR PLATE
______________________________________
Glucose 0.5%
(NH.sub.4)SO.sub.4
0.1%
KH.sub.2 PO.sub.4
0.3%
K.sub.2 HPO.sub.4
0.7%
MgSO.sub.4.7H.sub.2 O
0.01%
L-isoleucine 0.005%
Agar 2.0%
______________________________________
The growth degree was measured. The mutant requiring L-leucine was determined by one which is incapable or difficult to grow in the absence of L-leucine and capable to grow in the presence of L-leucine.
The results are shown in Table 4.
Providencia rettgeri NS-140, NS133I-69, and TP4-105-43 apparently require L-leucine for the growth thereof, while Providencia rettgeri TY-1 and NS-133 which are parent strains, do not.
TABLE 4
______________________________________
Amount of L-leucine
Microorganisms added (%) Growth*.sup.)
______________________________________
Providencia rettgeri
0 +
TY-1
(Parent strain)
Providencia rettgeri
0.01 +
TY-1
(Parent strain)
Providencia rettgeri
0 -
NS-140
Providencia rettgeri
0.01 +
NS-140
Providencia rettgeri
0 +
NS-133
(Parent strain)
Providencia rettgeri
0.01 +
NS-133
(Parent strain)
Providencia rettgeri
0 -
NS133I-69
Providencia rettgeri
0.01 +
NS133I-69
Providencia rettgeri
0 -
TP4-105-43
Providencia rettgeri
0.01 +
TP4-105-43
______________________________________
*.sup.) +: Grow
-: Not grow
Each microorganism shown in Table 6 was cultivated in bouillon liquid at 30° C. for 16 hours with shaking, was harvested, and washed well with physiological saline. The resulting cell suspension of each microorganism was inoculated into 5 ml of the minimal medium shown in Table 5 containing 0 g/l, 2.5 g/l, 5 g/l, 7.5 g/l, 10 g/l, respectively, and cultivated at 30° C. for 14 hours.
TABLE 5
______________________________________
Minimal medium
______________________________________
Glucose 0.5%
(NH.sub.4)SO.sub.4
0.1%
KH.sub.2 PO.sub.4
0.3%
K.sub.2 HPO.sub.4
0.7%
MgSO.sub.4.7H.sub.2 O
0.01%
L-isoleucine 0.005%
L-leucine 0.005%
Agar 2.0%
______________________________________
The growth degree was measured.
The results are shown in Table 6. Providencia rettgeri TP4-1105-43 is not inhibited the growth in the presence of the high concentration of S-aminoethyl-L-cysteine and has a strong resistance to S-aminoethyl-L-cysteine.
TABLE 6
______________________________________
Relative growth degree*.sup.) (%)
Amount of S-aminoethyl-L-cysteine
added (g/l)
Microorganisms
0 2.5 5 7.5 10
______________________________________
Providencia
100 4 4 4 4
rettgeri (61.0) (3.6) (4.4) (4.3) (4.6)**.sup.)
TP3-105
Providencia
100 92 83 55 55
rettgeri (68.2) (63.0) (56.9)
(37.6)
(37.5)**.sup.)
TP4-105-43
______________________________________
*.sup.) Relative growth degree is shown by the relative optical density o
the culture broth at 660 nm when the optical density of the cultrue broth
in the absence of Saminoethyl-L-cysteine is 100%.
**.sup.) Optical density of the culture broth at 660 nm.
Each microorganism shown in Table 8 was cultivated in bouillon liquid at 30° C. for 16 hours with shaking to give a seed culture broth. Then, 4 ml of seed culture broth was inoculated into 40 ml of the fermentation medium shown in Table 7 in 1-liter shaking flask. Cultivation was carried out at 30° C. for 90 hours with shaking conditions 150 rpm, 3 cm stroke).
TABLE 7
______________________________________
FERMENTATION MEDIUM*.sup.)
______________________________________
Glucose 8%
(autoclaved separately)
(NH.sub.4).sub.2 SO.sub.4
2%
KH.sub.2 PO.sub.4 0.1%
MgSO.sub.4.7H.sub.2 O 0.04%
Fe.sup.++ 2 ppm
Mn.sup.++ 2 ppm
L-Isoleucine 0.0025%
L-Leucine 0.08%**.sup.)
CaCO.sub.3 4%
(autoclaved separately)
pH 7.0
(neutralized with KOH)
______________________________________
*.sup.) Main culture medium was previously sterilized at 115° C.
for 10 minutes.
**.sup.) L-leucine was added in using NS140 and NS133I-69.
After cultivation, the medium was filtrated and removed off microorganisms and calcium carbonate, the amount of L-threonine accumulated in the resulting filtrate was quantitatively analyzed by automatic amino acid analyser (Produced by Japan Electric Co., JLC 200A). The results are shown in Table 8.
TABLE 8
______________________________________
Amount of L- Yield of
threonine L-threonine
Microorganisms accumulated (g/l)
(%)*.sup.)
______________________________________
Providencia rettgeri TY-1
9.6 12.0
(Parent strain)
Providencia rettgeri NS-140
13.2 16.5
Providencia rettgeri NS-133
11.5 14.4
(Parent strain)
Providencia rettgeri NS133I-69
15.2 19.0
Providencia rettgeri TP3-105
10.4 19.0
Providencia rettgeri TP4-105-43
20.7 26.7
______________________________________
*.sup.) Yield was calculated by weight of produced Lthreonine based on
consumed glucose.
In examples of the present invention, the amounts of L-threonine accumulated and the yields were efficiently improved, compared with the parent strains.
Providencia rettgeri NS-140 was cultivated in bouillon liquid medium at 30° C. for 16 hours with shaking to give a seed culture broth. 100 ml of the seed culture was transferred into a 2-liter jar fermentor, which contained 900 ml of the same fermentation medium as used in Example 1 except that 0.5% of (NH4)2 SO4 and 4.0% of glucose was used. Cultivation was carried out at 30° C. with agitation (800 rpm) and with aeration (1 liter of air per min). PH was controlled to 6.5 to 8.0 by 25% aqueous ammonia which was used as a nitrogen source. During cultivation, glucose was fed intermittently and 150 g of glucose was consumed.
After cultivation of 76 hours, 26.0 g/l for L-threonine, which was 17.3 wt % was based on glucose, was produced.
The culture broth was centrifuged and the microorganisms were removed off from the culture broth. 500 ml of the filtrate was passed through a column packed with supernatant strong cation exchange resin DIAION (Trade Mark) SK·1B [H type]. Then, the column was washed with water and thereafter the adsorbant in column was eluted by 2N aqueous ammonia. The eluent was decolorized and condensed under reduced pressure. Alcohol was added to the resultant and left standing under cooling to give crystals of L-threonine. The crystals were gathered, dried to give 11.5 g of L-threonine having 96% of the purity.
Claims (2)
1. A process for producing L-threonine by fermentation which comprises the steps of:
(a) culturing an L-threonine producing microorganism selected from the group consisting of Providencia rettgeri FERM BP-1050 (TP4-105-43), Providencia rettgeri FERM BP-1057 (NS-140) and Providencia rettgeri FERM BP-1058 NS133I-69) until L-threonine is accumulated in a culture broth, and
(b) recovering the accumulated L-threonine from the culture broth.
2. A process for producing L-threonine by fermentation which comprises the steps of:
(a) culturing an L-threonine producing microorganism selected from the group consisting of mutants of Providencia rettgeri FERM BP-871 (TY-1) and Providencia rettgeri FERM BP-3361 (NS133) until L-threonine is accumulated in a culture broth, said microorganism requiring at least leucine for the growth thereof; and
(b) recovering the accumulated L-threonine from the culture broth.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9958985A JPS61260891A (en) | 1985-05-13 | 1985-05-13 | Production of l-threonine by fermentation method |
| JP60-99589 | 1985-05-13 | ||
| JP4258086A JPH0673460B2 (en) | 1986-02-27 | 1986-02-27 | Method for producing L-threonine by fermentation method |
| JP61-42580 | 1986-02-27 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US06861076 Continuation | 1986-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US5098835A true US5098835A (en) | 1992-03-24 |
Family
ID=26382291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US07/357,690 Expired - Fee Related US5098835A (en) | 1985-05-13 | 1989-05-25 | Process for producing l-threonine by fermentation |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US5098835A (en) |
| EP (1) | EP0205849B1 (en) |
| DE (1) | DE3682709D1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5939307A (en) * | 1996-07-30 | 1999-08-17 | The Archer-Daniels-Midland Company | Strains of Escherichia coli, methods of preparing the same and use thereof in fermentation processes for l-threonine production |
| US20020106800A1 (en) * | 2000-09-28 | 2002-08-08 | Liaw Hungming J. | Escherichia coli strains which over-produce L-thereonine and processes for the production of L-threonine by fermentation |
| US20060205044A1 (en) * | 2005-03-11 | 2006-09-14 | D Elia John N | Escherichia coli strains that over-produce L-threonine and processes for their production |
| US20070015261A1 (en) * | 2005-06-20 | 2007-01-18 | D Elia John N | Altered glyoxylate shunt for improved production of aspartate-derived amino acids and chemicals |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0243496A4 (en) * | 1985-08-26 | 1988-01-28 | Toray Industries | Process for producing l-threonine by fermentation. |
| KR100815041B1 (en) | 1999-08-02 | 2008-03-18 | 아처 다니엘 미드랜드 캄파니 | Metabolic Engineering of Amino Acid Production |
| DE19959329A1 (en) | 1999-12-09 | 2001-06-13 | Degussa | Process for the fermentative production of L-amino acids using coryneform bacteria |
| DE102005043979A1 (en) | 2005-09-15 | 2007-03-22 | Forschungszentrum Jülich GmbH | Process for the production of amino acids in amino acid-producing microorganisms |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3375173A (en) * | 1964-07-01 | 1968-03-26 | Chugai Pharmaceutical Co Ltd | Fermentation process for the production of l-threonine |
| US3893888A (en) * | 1973-03-09 | 1975-07-08 | Ajinomoto Kk | Fermentative production of l-valine |
| JPS60180597A (en) * | 1984-02-27 | 1985-09-14 | Toray Ind Inc | Production of l-threonine by fermentation |
| EP0213536A2 (en) * | 1985-08-23 | 1987-03-11 | Toray Industries, Inc. | Process for producing L-threonine by fermentation |
| JPH08216690A (en) * | 1995-02-17 | 1996-08-27 | Honda Motor Co Ltd | Glass sunroof panel |
| JPH08224684A (en) * | 1994-11-28 | 1996-09-03 | Sollac | Device to guide and feed sheet base stock |
-
1986
- 1986-05-06 DE DE8686106204T patent/DE3682709D1/en not_active Expired - Fee Related
- 1986-05-06 EP EP86106204A patent/EP0205849B1/en not_active Expired
-
1989
- 1989-05-25 US US07/357,690 patent/US5098835A/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3375173A (en) * | 1964-07-01 | 1968-03-26 | Chugai Pharmaceutical Co Ltd | Fermentation process for the production of l-threonine |
| US3893888A (en) * | 1973-03-09 | 1975-07-08 | Ajinomoto Kk | Fermentative production of l-valine |
| JPS60180597A (en) * | 1984-02-27 | 1985-09-14 | Toray Ind Inc | Production of l-threonine by fermentation |
| EP0213536A2 (en) * | 1985-08-23 | 1987-03-11 | Toray Industries, Inc. | Process for producing L-threonine by fermentation |
| JPH08224684A (en) * | 1994-11-28 | 1996-09-03 | Sollac | Device to guide and feed sheet base stock |
| JPH08216690A (en) * | 1995-02-17 | 1996-08-27 | Honda Motor Co Ltd | Glass sunroof panel |
Non-Patent Citations (13)
| Title |
|---|
| Agric. Biol. Chem., vol. 38, No. 5, 1974, pp. 993 1000, Kase et al. * |
| Agric. Biol. Chem., vol. 38, No. 5, 1974, pp. 993-1000, Kase et al. |
| Chemical Abstracts, vol. 81, No. 4, Aug. 19, 1974, p. 310, No. 36502b. * |
| Lynn et al., In, "Amino Acids", Addison Wesley, 1983, pp. 173-179. |
| Lynn et al., In, Amino Acids , Addison Wesley, 1983, pp. 173 179. * |
| Stanbury et al., Principles of Fermentation Technology , 1989, pp. 40 47. * |
| Stanbury et al., Principles of Fermentation Technology, 1989, pp. 40-47. |
| Tosaka et al. (I), Agric. Biol. Chem. vol. 42, pp. 745 752, 1978. * |
| Tosaka et al. (I), Agric. Biol. Chem. vol. 42, pp. 745-752, 1978. |
| Tosaka et al. (II), Agric. Biol. Chem. vol. 42, pp. 1501 1506, 1978. * |
| Tosaka et al. (II), Agric. Biol. Chem. vol. 42, pp. 1501-1506, 1978. |
| Yoshinaga et al., In, "Amino Acids", pp. 405-429. |
| Yoshinaga et al., In, Amino Acids , pp. 405 429. * |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5939307A (en) * | 1996-07-30 | 1999-08-17 | The Archer-Daniels-Midland Company | Strains of Escherichia coli, methods of preparing the same and use thereof in fermentation processes for l-threonine production |
| US20020106800A1 (en) * | 2000-09-28 | 2002-08-08 | Liaw Hungming J. | Escherichia coli strains which over-produce L-thereonine and processes for the production of L-threonine by fermentation |
| US7220571B2 (en) | 2000-09-28 | 2007-05-22 | Archer-Daniels-Midland Company | Escherichia coli strains which over-produce L-threonine and processes for the production of L-threonine by fermentation |
| US20080166788A1 (en) * | 2000-09-28 | 2008-07-10 | Archer-Daniels-Midland Company | Escherichia Coli Strains which Over-Produce L-Threonine and Processes for the Production of L-Threonine by Fermentation |
| US7687253B2 (en) | 2000-09-28 | 2010-03-30 | Archer-Daniels-Midland Company | Escherichia coli strains which over-produce L-threonine and processes for the production of L-threonine by fermentation |
| US7767431B2 (en) | 2000-09-28 | 2010-08-03 | Archer-Daniels-Midland Company | Escherichia coli strains which over-produce L-threonine and processes for the production of L-threonine by fermentation |
| US8101386B2 (en) | 2000-09-28 | 2012-01-24 | Archer Daniels Midland Company | Escherichia coli strains which over-produce L-threonine and processes for the production of L-threonine by fermentation |
| US20060205044A1 (en) * | 2005-03-11 | 2006-09-14 | D Elia John N | Escherichia coli strains that over-produce L-threonine and processes for their production |
| US7723097B2 (en) | 2005-03-11 | 2010-05-25 | Archer-Daniels-Midland Company | Escherichia coli strains that over-produce L-threonine and processes for their production |
| US20100159537A1 (en) * | 2005-03-11 | 2010-06-24 | D Elia John N | Escherichia coli strains that over-produce l-threonine and processes for their production |
| US20070015261A1 (en) * | 2005-06-20 | 2007-01-18 | D Elia John N | Altered glyoxylate shunt for improved production of aspartate-derived amino acids and chemicals |
| US8187842B2 (en) | 2005-06-20 | 2012-05-29 | Archer Daniels Midland Company | Altered glyoxylate shunt for improved production of aspartate-derived amino acids and chemicals |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0205849A3 (en) | 1988-03-23 |
| EP0205849B1 (en) | 1991-12-04 |
| DE3682709D1 (en) | 1992-01-16 |
| EP0205849A2 (en) | 1986-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2082347C (en) | Process for producing l-isoleucine | |
| US4529697A (en) | Process for producing L-glutamic acid by fermentation | |
| HU215545B (en) | Process for producing l-threonine | |
| US5264353A (en) | Process for producing L-threonine by fermentation | |
| US5098835A (en) | Process for producing l-threonine by fermentation | |
| US3970519A (en) | Process for producing L-leucine | |
| US5217883A (en) | Process for producing amino acid | |
| JPS6257315B2 (en) | ||
| US5460958A (en) | Process for producing L-isoleucine by S-2-aminoethyl-L-cysteine or D-Serine resistant strains of E coli | |
| US3871960A (en) | Method of producing l-lysine by fermentation | |
| US5087566A (en) | Process for producing l-threonine | |
| EP0213536B1 (en) | Process for producing l-threonine by fermentation | |
| US5342766A (en) | Process for producing L-threonine by fermentation with P. rettgeri. | |
| US4389483A (en) | Method for producing L-glutamic acid by fermentation | |
| US4601982A (en) | Method for producing L-tryptophan by fermentation with a brevibacterium flavum mutant | |
| US4742007A (en) | Process for the preparation of L-tryptophan | |
| US3880741A (en) | Method of producing L-serine | |
| US5302521A (en) | Process for producing L-lysine by iodothyronine resistant strains of Mucorynebacterium glutamicum | |
| CA2037832A1 (en) | Process for producing l-threonine | |
| US4560652A (en) | Process for producing L-tryptophan by fermentation | |
| US5034319A (en) | Process for producing L-arginine | |
| CA1192156A (en) | Fermentative preparation of l-leucine | |
| US4421853A (en) | Fermentative preparation of L-leucine | |
| KR0146493B1 (en) | Process for producing l-alanine by fermentation | |
| US4123329A (en) | Process for producing L-lysine by fermentation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CC | Certificate of correction | ||
| FPAY | Fee payment |
Year of fee payment: 4 |
|
| REMI | Maintenance fee reminder mailed | ||
| LAPS | Lapse for failure to pay maintenance fees | ||
| FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20000324 |
|
| STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |